The deregulation of arachidonic acid metabolism in ovarian cancer

被引：1

作者：

Xia, Qiuyi ^{[1
]}

Gao, Wen ^{[2
]}

Yang, Jintao ^{[3
]}

Xing, Zhifang ^{[1
]}

Ji, Zhaodong ^{[1
]}

机构：

[1] Fudan Univ, Huashan Hosp, Dept Lab Med, Shanghai, Peoples R China

[2] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc IBMC, Canc Hosp,Inst Basic Med & Canc IBMC, Hangzhou, Zhejiang, Peoples R China

[3] Key Lab Digital Technol Med Diagnost Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2024年 / 14卷

关键词：

arachidonic acid; ovarian cancer; metabolic pathway; biological marker; targeted therapy; ACTIVATED-RECEPTOR-GAMMA; CELL-PROLIFERATION; TNF-ALPHA; KAPPA-B; COX-2; EXPRESSION; PATHWAY; 5-LIPOXYGENASE; ADENOCARCINOMA; ANGIOGENESIS;

D O I：

10.3389/fonc.2024.1381894

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Arachidonic acid (AA) is a crucial polyunsaturated fatty acid in the human body, metabolized through the pathways of COX, LOX, and cytochrome P450 oxidase to generate various metabolites. Recent studies have indicated that AA and its metabolites play significant regulatory roles in the onset and progression of ovarian cancer. This article examines the recent research advancements on the correlation between AA metabolites and ovarian cancer, both domestically and internationally, suggesting their potential use as biological markers for early diagnosis, targeted therapy, and prognosis monitoring.

引用

页数：10

共 50 条

[31] Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer
Zhao, Yawei
Cui, Lianzhi
Pan, Yue
Shao, Dan
Zheng, Xiao
Zhang, Fan
Zhang, Hansi
He, Kan
Chen, Li
CELL PROLIFERATION, 2017, 50 (06)
[32] Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition
Li, Xiao-Jun
Suo, Ping
Wang, Yan-Ni
Zou, Liang
Nie, Xiao-Li
Zhao, Ying-Yong
Miao, Hua
FRONTIERS IN PHARMACOLOGY, 2024, 15
[33] Pitfalls in the use of arachidonic acid oxidation products to assign lipoxygenase activity in cancer cells
Niknami, Marzieh
Dong, Qihan
Witting, Paul K.
FREE RADICAL RESEARCH, 2009, 43 (10) : 951 - 956
[34] Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability
Modi, Hiren R.
Taha, Ameer Y.
Kim, Hyung-Wook
Chang, Lisa
Rapoport, Stanley I.
Cheon, Yewon
JOURNAL OF NEUROCHEMISTRY, 2013, 124 (03) : 376 - 387
[35] Lipid Peroxidation via Regulating the Metabolism of Docosahexaenoic Acid and Arachidonic Acid in Autistic Behavioral Symptoms
Yui, Kunio
Imataka, George
Shiohama, Tadashi
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (11) : 9149 - 9164
[36] Comprehensive analysis reveals an arachidonic acid metabolism-related gene signature in patients with pancreatic ductal adenocarcinoma
ZHU, H. U. I. L. I.
XIAO, L. I. N. A.
YIN, X. I. A.
XIANG, S. H. I. B. I. N. G.
WANG, C. H. U. N. H. U., I
BIOCELL, 2022, 46 (10) : 2241 - 2256
[37] Choline Metabolism Alteration: A Focus on Ovarian Cancer
Bagnoli, Marina
Granata, Anna
Nicoletti, Roberta
Krishnamachary, Balaji
Bhujwalla, Zaver M.
Canese, Rossella
Podo, Franca
Canevari, Silvana
Iorio, Egidio
Mezzanzanica, Delia
FRONTIERS IN ONCOLOGY, 2016, 6
[38] Transcriptome data analysis of primary cardiomyopathies reveals perturbations in arachidonic acid metabolism
Chauhan, Pankaj Kumar
Sowdhamini, Ramanathan
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[39] Arachidonic acid metabolism and inflammatory biomarkers associated with exposure to polycyclic aromatic hydrocarbons
Lin, Yan
Lu, Xinchen
Qiu, Xinghua
Yin, Fen
Faull, Kym F.
Tseng, Chi-Hong
Zhang, Junfeng
Fiehn, Oliver
Zhu, Tong
Araujo, Jesus A.
Zhu, Yifang
ENVIRONMENTAL RESEARCH, 2022, 212
[40] Role of arachidonic acid metabolism in osteosarcoma prognosis by integrating WGCNA and bioinformatics analysis
Wang, Yaling
Hsu, Peichun
Hu, Haiyan
Lin, Feng
Wei, Xiaokang
BMC CANCER, 2025, 25 (01)

← 1 2 3 4 5 →